Oberweis Asset Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-51,900
Closed -$929K – 182
2022
Q2
$929K Buy
51,900
+900
+2% +$21.1K 0.24% 92
2022
Q1
$1.47M Buy
+51,000
New +$1.4M 0.3% 71
2021
Q4
– Sell
-42,300
Closed -$1.15M – 173
2021
Q3
$1.15M Buy
42,300
+5,800
+16% +$155K 0.24% 74
2021
Q2
$1.03M Buy
+36,500
New +$972K 0.22% 84
2016
Q2
– Sell
-22,000
Closed -$575K – 187
2016
Q1
$575K Buy
22,000
+200
+0.9% +$4.63K 0.17% 96
2015
Q4
$562K Buy
+21,800
New +$588K 0.16% 112

Other funds holding TBI

Oberweis Asset Management's TBI Position: Q3 2022 in Review

Oberweis Asset Management sold out of Trueblue (TBI) in Q3 2022, closing a stake of 51,900 shares — an estimated $929K sold.

Oberweis Asset Management first reported a position in TBI in Q4 2015 and held it in 6 quarters. The position peaked at $1.47M in Q1 2022. 172 funds tracked by Wall St. Rank hold TBI as of Q3 2022.

  • Oberweis Asset Management reported no remaining Trueblue position as of Q3 2022 after selling out during the quarter.
  • Oberweis Asset Management sold 51,900 Trueblue shares in Q3 2022, an estimated $929K.
  • Oberweis Asset Management first reported a position in Trueblue in Q4 2015 and held it in 6 quarters.
  • Oberweis Asset Management's Trueblue position peaked at $1.47M in Q1 2022.
  • 172 funds tracked by Wall St. Rank held Trueblue as of Q3 2022.

Based on Oberweis Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.